Sign in
CompletedPhase 4

The Impact of Genicular Nerves Chemical Neurolysis on the Quality of Life of Patients with Advanced Knee Osteoarthritis.

Key facts

Who runs it
Poznan University of Medical Sciences
Where
Poland1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 4
People taking part
100 people enrolled
Started
17 Oct 2023
Ended
14 Jan 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • 0.9% Sodium chloride
  • 95% ethanol
Record updated
21 January 2025

Who can take part

Age
18 years to 110 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Patients of the Pain Treatment Clinic of the Transfiguration of Jesus Clinical Hospital of the Medical University of Poznań will be qualified for the study
  • patients with gonarthrosis who failed to achieve satisfactory pain control (NRS>3) despite the use of NSAIDs, Paracetamol, and co-analgesics
  • Age of patients: from 18 to 110 years of age
  • Caucasian patients can give informed, complete, written consent

Who cannot take part

  • suspected or diagnosed opioid dependence syndrome
  • active cancer
  • dementia

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Genicular nerves chemical neurolysis in advanced osteoarthritis of the knee joint.

The 2 groups in the trial

  • Sham blocksExisting treatment, for comparison

    US-guided Bilateral genicular nerve block with 0,9% NaCl

    Treatment: 0.9% Sodium chloride

  • Genicular nerve neurolysisExisting treatment, for comparison

    US-guided Bilateral genicular nerve neurolysis with 0,5ml 95% ethanol

    Treatment: 95% ethanol

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Impact of Genicular Nerves Chemical Neurolysis on the Quality of Life of Patients with Advanced Knee Osteoarthritis. a Randomized, Double-blinded, Clinical Trial
Record updated
21 January 2025